ELICIT研究:评估改善临床试验知情同意干预措施的国际核心结局集
ELICIT研究通过系统综述、半结构化访谈、在线德尔菲调查和面对面共识会议,开发了评估改善随机对照试验知情同意干预措施的核心结局集。最终达成共识的12个核心结局包括治疗性误解、决策舒适度、决策真实性、试验沟通、赋权、利他感、均衡、知识、问题显著性、理解、决策过程帮助性和试验脱落。该核心结局集为未来相关研究提供了国际公认的最小测量集。
要点
- ELICIT核心结局集包含12个结局,用于评估改善临床试验知情同意干预措施。
- 核心结局涵盖治疗性误解、决策舒适度、决策真实性、知识、理解等维度。
- 使用该核心集可确保未来研究结果的可比性和利益相关者相关性。
核心结论
- ELICIT核心结局集是首个国际公认的最小结局集,用于所有未来评估改善随机对照试验参与决策干预措施的研究。
研究设计与样本
- 国际混合方法研究,包括系统综述、半结构化访谈、在线德尔菲调查和面对面共识会议。
- 访谈25人,德尔菲调查79人参与两轮评分,共识会议18人参加。
主要发现
- 文献综述和利益相关者访谈初步确定1045个报告结局,归纳为40个独立结局。
- 40个结局在两轮在线德尔菲调查中评分,最终共识达成12个核心结局。
- 12个核心结局包括治疗性误解、决策舒适度、决策真实性、试验沟通、赋权、利他感、均衡、知识、问题显著性、理解、决策过程帮助性和试验脱落。
关键数值与推荐
- 共识达成12个核心结局:治疗性误解、决策舒适度、决策真实性、沟通、赋权、利他感、均衡、知识、问题显著性、理解、决策过程帮助性、试验脱落。
临床怎么用
- 未来评估改善临床试验知情同意干预措施的研究应测量ELICIT核心结局集,以确保结果可比性和利益相关者相关性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To develop a core outcome set for the evaluation of interventions that aim to improve how people make decisions about whether to participate in randomized controlled trials (of healthcare interventions), the ELICIT Study. STUDY DESIGN: International mixed-method study involving a systematic review of existing outcomes, semi-structured interviews, an online Delphi survey, and a face-to-face consensus meeting. RESULTS: The literature review and stakeholder interviews (n = 25) initially identified 1045 reported outcomes that were grouped into 40 individually distinct outcomes. These 40 outcomes were scored for importance in two rounds of an online Delphi survey (n = 79), with 18 people attending the consensus meeting. Consensus was reached on 12 core outcomes: therapeutic misconception; comfort with decision; authenticity of decision; communication about the trial; empowerment; sense of altruism; equipoise; knowledge; salience of questions; understanding, how helpful the process was for decision making; and trial attrition. CONCLUSION: The ELICIT core outcome set is the first internationally agreed minimum set of outcomes deemed essential to be measured in all future studies evaluating interventions to improve decisions about participating in an randomized controlled trial. Use of the ELICIT core set will ensure that results from these trials are comparable and relevant to all stakeholders. REGISTRATION: COMET database - http://www.comet-initiative.org/Studies/Details/595.
引用
- Gillies K, Williamson PR, Entwistle VA, et al. An international core outcome set for evaluating interventions to improve informed consent to clinical trials: The ELICIT Study. J Clin Epidemiol. 2021. PMID: 33652081. doi:10.1016/j.jclinepi.2021.02.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。